

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.39416922 |
| 2 | neuronal action potential propagation (GO:0019227) | 5.94709939 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.94512317 |
| 4 | vocalization behavior (GO:0071625) | 5.90119591 |
| 5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.75062392 |
| 6 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.73726738 |
| 7 | synaptic vesicle maturation (GO:0016188) | 5.55238809 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 5.41809508 |
| 9 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.29506927 |
| 10 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.24649023 |
| 11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.14619348 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.13724541 |
| 13 | cerebellar granule cell differentiation (GO:0021707) | 5.13521035 |
| 14 | protein localization to synapse (GO:0035418) | 5.11552013 |
| 15 | neurotransmitter-gated ion channel clustering (GO:0072578) | 5.06079110 |
| 16 | glutamate secretion (GO:0014047) | 5.04815486 |
| 17 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.00367463 |
| 18 | glutamate receptor signaling pathway (GO:0007215) | 4.97514560 |
| 19 | synaptic transmission, glutamatergic (GO:0035249) | 4.96121695 |
| 20 | neurotransmitter secretion (GO:0007269) | 4.67920870 |
| 21 | * neuron-neuron synaptic transmission (GO:0007270) | 4.64752628 |
| 22 | negative T cell selection (GO:0043383) | 4.61119178 |
| 23 | gamma-aminobutyric acid transport (GO:0015812) | 4.59625474 |
| 24 | neuron cell-cell adhesion (GO:0007158) | 4.57187528 |
| 25 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.54985275 |
| 26 | positive regulation of synapse maturation (GO:0090129) | 4.51316330 |
| 27 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.51231394 |
| 28 | regulation of synaptic vesicle transport (GO:1902803) | 4.50760019 |
| 29 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.48861683 |
| 30 | regulation of synapse structural plasticity (GO:0051823) | 4.46050218 |
| 31 | exploration behavior (GO:0035640) | 4.44306104 |
| 32 | positive regulation of membrane potential (GO:0045838) | 4.36420766 |
| 33 | negative thymic T cell selection (GO:0045060) | 4.32093269 |
| 34 | postsynaptic membrane organization (GO:0001941) | 4.30012195 |
| 35 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.27383741 |
| 36 | cerebellar Purkinje cell differentiation (GO:0021702) | 4.21113978 |
| 37 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.20702497 |
| 38 | regulation of postsynaptic membrane potential (GO:0060078) | 4.17992272 |
| 39 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.16337038 |
| 40 | presynaptic membrane assembly (GO:0097105) | 4.15211497 |
| 41 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.13705288 |
| 42 | negative regulation of cell killing (GO:0031342) | 4.12488121 |
| 43 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.12488121 |
| 44 | auditory behavior (GO:0031223) | 4.09484616 |
| 45 | positive T cell selection (GO:0043368) | 4.07659987 |
| 46 | cellular potassium ion homeostasis (GO:0030007) | 4.07139653 |
| 47 | presynaptic membrane organization (GO:0097090) | 4.05550080 |
| 48 | regulation of ARF protein signal transduction (GO:0032012) | 4.03964962 |
| 49 | * long-term memory (GO:0007616) | 3.94078125 |
| 50 | mechanosensory behavior (GO:0007638) | 3.86688144 |
| 51 | prepulse inhibition (GO:0060134) | 3.85598827 |
| 52 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.82017672 |
| 53 | layer formation in cerebral cortex (GO:0021819) | 3.78123809 |
| 54 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.75639147 |
| 55 | long-term synaptic potentiation (GO:0060291) | 3.75445259 |
| 56 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.74074724 |
| 57 | dendritic spine morphogenesis (GO:0060997) | 3.73461378 |
| 58 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.69824571 |
| 59 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.69798934 |
| 60 | regulation of neurotransmitter secretion (GO:0046928) | 3.68482130 |
| 61 | transmission of nerve impulse (GO:0019226) | 3.67349945 |
| 62 | response to histamine (GO:0034776) | 3.66529713 |
| 63 | neurotransmitter transport (GO:0006836) | 3.66021344 |
| 64 | regulation of synaptic plasticity (GO:0048167) | 3.63900506 |
| 65 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.62521997 |
| 66 | neuromuscular process controlling balance (GO:0050885) | 3.62065452 |
| 67 | regulation of synapse maturation (GO:0090128) | 3.61571465 |
| 68 | behavioral response to cocaine (GO:0048148) | 3.61326508 |
| 69 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.60808512 |
| 70 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.58004572 |
| 71 | membrane depolarization (GO:0051899) | 3.57925682 |
| 72 | response to pheromone (GO:0019236) | 3.55424860 |
| 73 | activated T cell proliferation (GO:0050798) | 3.52704299 |
| 74 | L-amino acid import (GO:0043092) | 3.50528080 |
| 75 | cell differentiation in hindbrain (GO:0021533) | 3.49362471 |
| 76 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.48878873 |
| 77 | sodium ion export (GO:0071436) | 3.48169722 |
| 78 | positive regulation of neurotransmitter transport (GO:0051590) | 3.48135309 |
| 79 | response to auditory stimulus (GO:0010996) | 3.46747061 |
| 80 | regulation of neurotransmitter transport (GO:0051588) | 3.46598376 |
| 81 | regulation of neurotransmitter levels (GO:0001505) | 3.46318738 |
| 82 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.43492872 |
| 83 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.35942121 |
| 84 | membrane depolarization during action potential (GO:0086010) | 3.35937812 |
| 85 | membrane hyperpolarization (GO:0060081) | 3.35912885 |
| 86 | synapse assembly (GO:0007416) | 3.35505742 |
| 87 | activation of protein kinase A activity (GO:0034199) | 3.34486207 |
| 88 | T cell selection (GO:0045058) | 3.32939750 |
| 89 | response to interleukin-15 (GO:0070672) | 3.31645231 |
| 90 | adult walking behavior (GO:0007628) | 3.31491389 |
| 91 | learning (GO:0007612) | 3.28246490 |
| 92 | synaptic vesicle endocytosis (GO:0048488) | 3.26865479 |
| 93 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.26758032 |
| 94 | cellular response to interleukin-15 (GO:0071350) | 3.26756092 |
| 95 | long term synaptic depression (GO:0060292) | 3.24799810 |
| 96 | behavioral fear response (GO:0001662) | 3.24043839 |
| 97 | behavioral defense response (GO:0002209) | 3.24043839 |
| 98 | thymic T cell selection (GO:0045061) | 3.23557067 |
| 99 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.22544835 |
| 100 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.22013090 |
| 101 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.20845496 |
| 102 | positive regulation of dendritic spine development (GO:0060999) | 3.20308642 |
| 103 | regulation of vesicle fusion (GO:0031338) | 3.18279419 |
| 104 | regulation of dendritic spine development (GO:0060998) | 3.17795310 |
| 105 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.16815198 |
| 106 | fear response (GO:0042596) | 3.16536229 |
| 107 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.15773695 |
| 108 | neuromuscular process controlling posture (GO:0050884) | 3.14910559 |
| 109 | positive thymic T cell selection (GO:0045059) | 3.13687886 |
| 110 | visual learning (GO:0008542) | 3.12858059 |
| 111 | positive regulation of synaptic transmission (GO:0050806) | 3.09430465 |
| 112 | proline transport (GO:0015824) | 3.08725944 |
| 113 | * synaptic transmission (GO:0007268) | 3.08009019 |
| 114 | neuromuscular process (GO:0050905) | 3.07489966 |
| 115 | regulation of synaptic transmission (GO:0050804) | 3.02899357 |
| 116 | dendrite morphogenesis (GO:0048813) | 3.01656324 |
| 117 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.97963060 |
| 118 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.96181215 |
| 119 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.93744489 |
| 120 | potassium ion import (GO:0010107) | 2.88578592 |
| 121 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.88110404 |
| 122 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.87715813 |
| 123 | T cell migration (GO:0072678) | 2.86194131 |
| 124 | tolerance induction (GO:0002507) | 2.82818757 |
| 125 | neuronal ion channel clustering (GO:0045161) | 2.80283204 |
| 126 | negative regulation of T cell mediated immunity (GO:0002710) | 2.79813400 |
| 127 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.79513647 |
| 128 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.79350522 |
| 129 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.73771245 |
| 130 | regulation of Rap GTPase activity (GO:0032317) | 2.72896711 |
| 131 | positive regulation of granulocyte differentiation (GO:0030854) | 2.72865447 |
| 132 | neurotransmitter uptake (GO:0001504) | 2.72180746 |
| 133 | nerve growth factor signaling pathway (GO:0038180) | 2.71519518 |
| 134 | amino acid import (GO:0043090) | 2.71353055 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.91938165 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.01508415 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.78691265 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.54205407 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.17635307 |
| 6 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.17082058 |
| 7 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.15908370 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.86020414 |
| 9 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.75759235 |
| 10 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.74714538 |
| 11 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.74714538 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.69083552 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.64636398 |
| 14 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.60463005 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.56499318 |
| 16 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.52256857 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.49702294 |
| 18 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.48635695 |
| 19 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.47504346 |
| 20 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.45670124 |
| 21 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.43132174 |
| 22 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.33866289 |
| 23 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.27209889 |
| 24 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.24555405 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.21338254 |
| 26 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.18448445 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.16076960 |
| 28 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.98757363 |
| 29 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.96440011 |
| 30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.94559299 |
| 31 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.87735878 |
| 32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.86386507 |
| 33 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.80090426 |
| 34 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.77902423 |
| 35 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.76673919 |
| 36 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.76262090 |
| 37 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.73581564 |
| 38 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.70459246 |
| 39 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.69493560 |
| 40 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.56821151 |
| 41 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.56762741 |
| 42 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.55478184 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.47633634 |
| 44 | P300_19829295_ChIP-Seq_ESCs_Human | 1.38069607 |
| 45 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37337320 |
| 46 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.36522197 |
| 47 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.31578976 |
| 48 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.30898405 |
| 49 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.28316554 |
| 50 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27354118 |
| 51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.27120783 |
| 52 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.25918404 |
| 53 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.25726837 |
| 54 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.25067284 |
| 55 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.24434127 |
| 56 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.22556625 |
| 57 | AR_19668381_ChIP-Seq_PC3_Human | 1.22415249 |
| 58 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.22301888 |
| 59 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.19697002 |
| 60 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.18504773 |
| 61 | TCF4_23295773_ChIP-Seq_U87_Human | 1.17449582 |
| 62 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16876849 |
| 63 | * MYB_26560356_Chip-Seq_TH2_Human | 1.16869090 |
| 64 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.14932377 |
| 65 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.14186714 |
| 66 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.13708265 |
| 67 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.12787462 |
| 68 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.12640809 |
| 69 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.11755045 |
| 70 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.11673121 |
| 71 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.11207227 |
| 72 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.10993782 |
| 73 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.09687454 |
| 74 | TP53_16413492_ChIP-PET_HCT116_Human | 1.09425991 |
| 75 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09282474 |
| 76 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.08129959 |
| 77 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.08044980 |
| 78 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.07268245 |
| 79 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.05324353 |
| 80 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.05221199 |
| 81 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.04264523 |
| 82 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.03913400 |
| 83 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.03806157 |
| 84 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.03348957 |
| 85 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.03193408 |
| 86 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.03012466 |
| 87 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03011051 |
| 88 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02618530 |
| 89 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.02421670 |
| 90 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.02052609 |
| 91 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.01791068 |
| 92 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.01678897 |
| 93 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01416346 |
| 94 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.01394727 |
| 95 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01297365 |
| 96 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00394868 |
| 97 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.99098880 |
| 98 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97692171 |
| 99 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97531805 |
| 100 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.96933315 |
| 101 | KDM2B_26808549_Chip-Seq_K562_Human | 0.96596453 |
| 102 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.96591618 |
| 103 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.95136598 |
| 104 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94241974 |
| 105 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.92621204 |
| 106 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.92354149 |
| 107 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.92320700 |
| 108 | RXR_22108803_ChIP-Seq_LS180_Human | 0.92020307 |
| 109 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.91037407 |
| 110 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.90862249 |
| 111 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90761763 |
| 112 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.90761763 |
| 113 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.90280370 |
| 114 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.89876885 |
| 115 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89762789 |
| 116 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.89120926 |
| 117 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.87245792 |
| 118 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86883905 |
| 119 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86688638 |
| 120 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85116035 |
| 121 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.84139620 |
| 122 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.83966637 |
| 123 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.83800495 |
| 124 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.82804520 |
| 125 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.82553609 |
| 126 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.82447850 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.41489149 |
| 2 | MP0003880_abnormal_central_pattern | 4.79776245 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.43734184 |
| 4 | MP0009046_muscle_twitch | 3.96387905 |
| 5 | * MP0009745_abnormal_behavioral_response | 3.67773729 |
| 6 | MP0004270_analgesia | 3.61855071 |
| 7 | MP0002822_catalepsy | 3.54256474 |
| 8 | * MP0002063_abnormal_learning/memory/cond | 3.41331411 |
| 9 | MP0002064_seizures | 3.33658959 |
| 10 | MP0001968_abnormal_touch/_nociception | 3.21395841 |
| 11 | * MP0002572_abnormal_emotion/affect_behav | 2.93409282 |
| 12 | MP0002272_abnormal_nervous_system | 2.92596759 |
| 13 | MP0008569_lethality_at_weaning | 2.78330450 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.73611341 |
| 15 | MP0005423_abnormal_somatic_nervous | 2.68275288 |
| 16 | MP0003763_abnormal_thymus_physiology | 2.64169172 |
| 17 | MP0001486_abnormal_startle_reflex | 2.64003929 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.36907217 |
| 19 | MP0001501_abnormal_sleep_pattern | 2.33240066 |
| 20 | * MP0002067_abnormal_sensory_capabilities | 2.31495837 |
| 21 | MP0002736_abnormal_nociception_after | 2.30997381 |
| 22 | MP0001440_abnormal_grooming_behavior | 2.18485071 |
| 23 | MP0003879_abnormal_hair_cell | 2.04721986 |
| 24 | MP0002184_abnormal_innervation | 2.02858227 |
| 25 | MP0002733_abnormal_thermal_nociception | 1.99288767 |
| 26 | MP0001188_hyperpigmentation | 1.89932912 |
| 27 | MP0002557_abnormal_social/conspecific_i | 1.89637229 |
| 28 | * MP0001970_abnormal_pain_threshold | 1.89015230 |
| 29 | * MP0004924_abnormal_behavior | 1.79282572 |
| 30 | * MP0005386_behavior/neurological_phenoty | 1.79282572 |
| 31 | MP0008877_abnormal_DNA_methylation | 1.75885032 |
| 32 | MP0005671_abnormal_response_to | 1.71103072 |
| 33 | MP0004811_abnormal_neuron_physiology | 1.69563910 |
| 34 | MP0005409_darkened_coat_color | 1.67732606 |
| 35 | MP0004145_abnormal_muscle_electrophysio | 1.65084870 |
| 36 | MP0001984_abnormal_olfaction | 1.63289917 |
| 37 | MP0002909_abnormal_adrenal_gland | 1.62923992 |
| 38 | MP0009780_abnormal_chondrocyte_physiolo | 1.62615985 |
| 39 | MP0003329_amyloid_beta_deposits | 1.55419076 |
| 40 | MP0000778_abnormal_nervous_system | 1.54476144 |
| 41 | MP0002009_preneoplasia | 1.50226590 |
| 42 | MP0003633_abnormal_nervous_system | 1.47219750 |
| 43 | MP0000955_abnormal_spinal_cord | 1.46610439 |
| 44 | MP0005646_abnormal_pituitary_gland | 1.46342548 |
| 45 | * MP0002066_abnormal_motor_capabilities/c | 1.45685546 |
| 46 | MP0001502_abnormal_circadian_rhythm | 1.42132197 |
| 47 | MP0004142_abnormal_muscle_tone | 1.38899914 |
| 48 | * MP0002882_abnormal_neuron_morphology | 1.28407748 |
| 49 | MP0004885_abnormal_endolymph | 1.25856140 |
| 50 | MP0008872_abnormal_physiological_respon | 1.25597278 |
| 51 | MP0000703_abnormal_thymus_morphology | 1.23798814 |
| 52 | MP0003631_nervous_system_phenotype | 1.21949976 |
| 53 | MP0000569_abnormal_digit_pigmentation | 1.19528624 |
| 54 | MP0003787_abnormal_imprinting | 1.19486169 |
| 55 | MP0001529_abnormal_vocalization | 1.19439388 |
| 56 | MP0004742_abnormal_vestibular_system | 1.19404169 |
| 57 | MP0004858_abnormal_nervous_system | 1.18073939 |
| 58 | MP0001800_abnormal_humoral_immune | 1.17664298 |
| 59 | MP0003866_abnormal_defecation | 1.17171159 |
| 60 | MP0004130_abnormal_muscle_cell | 1.14701973 |
| 61 | MP0003122_maternal_imprinting | 1.10710933 |
| 62 | MP0008874_decreased_physiological_sensi | 1.09725991 |
| 63 | MP0006276_abnormal_autonomic_nervous | 1.09616429 |
| 64 | MP0001905_abnormal_dopamine_level | 1.06854096 |
| 65 | MP0008057_abnormal_DNA_replication | 1.06760988 |
| 66 | * MP0002152_abnormal_brain_morphology | 1.04140121 |
| 67 | MP0004381_abnormal_hair_follicle | 1.04014307 |
| 68 | MP0000015_abnormal_ear_pigmentation | 1.02457599 |
| 69 | MP0005645_abnormal_hypothalamus_physiol | 0.97378460 |
| 70 | MP0003121_genomic_imprinting | 0.94016732 |
| 71 | MP0002229_neurodegeneration | 0.90446500 |
| 72 | MP0005000_abnormal_immune_tolerance | 0.89453245 |
| 73 | MP0002398_abnormal_bone_marrow | 0.89302512 |
| 74 | MP0001986_abnormal_taste_sensitivity | 0.88823498 |
| 75 | MP0003632_abnormal_nervous_system | 0.88747092 |
| 76 | MP0002420_abnormal_adaptive_immunity | 0.85838851 |
| 77 | MP0002069_abnormal_eating/drinking_beha | 0.85800922 |
| 78 | MP0000920_abnormal_myelination | 0.83272818 |
| 79 | MP0002876_abnormal_thyroid_physiology | 0.82861595 |
| 80 | MP0001819_abnormal_immune_cell | 0.82694198 |
| 81 | MP0001177_atelectasis | 0.82419028 |
| 82 | MP0005310_abnormal_salivary_gland | 0.81231780 |
| 83 | MP0005551_abnormal_eye_electrophysiolog | 0.79825729 |
| 84 | MP0001963_abnormal_hearing_physiology | 0.79821243 |
| 85 | MP0002723_abnormal_immune_serum | 0.79384416 |
| 86 | MP0003123_paternal_imprinting | 0.75891571 |
| 87 | MP0003646_muscle_fatigue | 0.75639932 |
| 88 | MP0003724_increased_susceptibility_to | 0.74867647 |
| 89 | MP0000013_abnormal_adipose_tissue | 0.74772970 |
| 90 | MP0005535_abnormal_body_temperature | 0.74357885 |
| 91 | MP0000751_myopathy | 0.73199849 |
| 92 | MP0000631_abnormal_neuroendocrine_gland | 0.72834315 |
| 93 | MP0003075_altered_response_to | 0.72431699 |
| 94 | * MP0000716_abnormal_immune_system | 0.72359018 |
| 95 | MP0004510_myositis | 0.71859604 |
| 96 | MP0004484_altered_response_of | 0.71323926 |
| 97 | MP0004085_abnormal_heartbeat | 0.68431587 |
| 98 | MP0003045_fibrosis | 0.67566092 |
| 99 | MP0001851_eye_inflammation | 0.67494196 |
| 100 | MP0004147_increased_porphyrin_level | 0.67052044 |
| 101 | MP0005394_taste/olfaction_phenotype | 0.66943689 |
| 102 | MP0005499_abnormal_olfactory_system | 0.66943689 |
| 103 | MP0002928_abnormal_bile_duct | 0.64730641 |
| 104 | MP0002163_abnormal_gland_morphology | 0.64699408 |
| 105 | MP0005174_abnormal_tail_pigmentation | 0.63657689 |
| 106 | MP0003303_peritoneal_inflammation | 0.63377800 |
| 107 | MP0000604_amyloidosis | 0.62992195 |
| 108 | MP0004215_abnormal_myocardial_fiber | 0.62712616 |
| 109 | MP0002752_abnormal_somatic_nervous | 0.62493599 |
| 110 | MP0003436_decreased_susceptibility_to | 0.62441537 |
| 111 | MP0010386_abnormal_urinary_bladder | 0.61496038 |
| 112 | MP0002638_abnormal_pupillary_reflex | 0.61455936 |
| 113 | MP0001835_abnormal_antigen_presentation | 0.61042687 |
| 114 | MP0000685_abnormal_immune_system | 0.59699310 |
| 115 | MP0002722_abnormal_immune_system | 0.59362277 |
| 116 | MP0001485_abnormal_pinna_reflex | 0.57077605 |
| 117 | MP0003690_abnormal_glial_cell | 0.56861332 |
| 118 | MP0003634_abnormal_glial_cell | 0.56860377 |
| 119 | MP0010769_abnormal_survival | 0.56761584 |
| 120 | MP0008961_abnormal_basal_metabolism | 0.55560432 |
| 121 | MP0010768_mortality/aging | 0.54112949 |
| 122 | MP0004043_abnormal_pH_regulation | 0.53386666 |
| 123 | MP0001943_abnormal_respiration | 0.52685812 |
| 124 | MP0002082_postnatal_lethality | 0.52475735 |
| 125 | MP0010770_preweaning_lethality | 0.52475735 |
| 126 | * MP0003956_abnormal_body_size | 0.51991301 |
| 127 | MP0003137_abnormal_impulse_conducting | 0.50646369 |
| 128 | MP0001664_abnormal_digestion | 0.48383249 |
| 129 | MP0005187_abnormal_penis_morphology | 0.46862841 |
| 130 | MP0002095_abnormal_skin_pigmentation | 0.44328722 |
| 131 | MP0001348_abnormal_lacrimal_gland | 0.43758640 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.80950133 |
| 2 | Myokymia (HP:0002411) | 6.70967980 |
| 3 | Focal seizures (HP:0007359) | 6.25105665 |
| 4 | Visual hallucinations (HP:0002367) | 5.66649591 |
| 5 | Progressive cerebellar ataxia (HP:0002073) | 5.57887119 |
| 6 | Gaze-evoked nystagmus (HP:0000640) | 5.52722157 |
| 7 | Epileptic encephalopathy (HP:0200134) | 5.48176420 |
| 8 | Action tremor (HP:0002345) | 5.30811792 |
| 9 | Atonic seizures (HP:0010819) | 5.22142067 |
| 10 | Febrile seizures (HP:0002373) | 5.20171125 |
| 11 | Broad-based gait (HP:0002136) | 4.97803578 |
| 12 | Absence seizures (HP:0002121) | 4.49585610 |
| 13 | Dysmetric saccades (HP:0000641) | 4.33251235 |
| 14 | Poor eye contact (HP:0000817) | 4.26591639 |
| 15 | Scanning speech (HP:0002168) | 4.24232309 |
| 16 | Impaired smooth pursuit (HP:0007772) | 4.11510750 |
| 17 | Dialeptic seizures (HP:0011146) | 4.07935477 |
| 18 | Hyperventilation (HP:0002883) | 4.05510139 |
| 19 | Dysdiadochokinesis (HP:0002075) | 4.00223682 |
| 20 | Annular pancreas (HP:0001734) | 3.92651609 |
| 21 | Truncal ataxia (HP:0002078) | 3.78230046 |
| 22 | Generalized tonic-clonic seizures (HP:0002069) | 3.76759686 |
| 23 | T lymphocytopenia (HP:0005403) | 3.76627327 |
| 24 | Impaired social interactions (HP:0000735) | 3.64964458 |
| 25 | Abnormal social behavior (HP:0012433) | 3.64964458 |
| 26 | Abnormality of ocular smooth pursuit (HP:0000617) | 3.59463589 |
| 27 | Dysmetria (HP:0001310) | 3.43625580 |
| 28 | Genetic anticipation (HP:0003743) | 3.41862019 |
| 29 | Abnormality of T cell number (HP:0011839) | 3.39057414 |
| 30 | Stereotypic behavior (HP:0000733) | 3.26584589 |
| 31 | Depression (HP:0000716) | 3.25823293 |
| 32 | Abnormal eating behavior (HP:0100738) | 3.17189464 |
| 33 | Hemiplegia (HP:0002301) | 3.08962058 |
| 34 | Anxiety (HP:0000739) | 3.05207514 |
| 35 | Severe combined immunodeficiency (HP:0004430) | 3.02106369 |
| 36 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.97999057 |
| 37 | Abnormality of binocular vision (HP:0011514) | 2.95665959 |
| 38 | Diplopia (HP:0000651) | 2.95665959 |
| 39 | Hemiparesis (HP:0001269) | 2.92295106 |
| 40 | Intention tremor (HP:0002080) | 2.88446319 |
| 41 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.81692348 |
| 42 | Slow saccadic eye movements (HP:0000514) | 2.80104735 |
| 43 | Status epilepticus (HP:0002133) | 2.77256660 |
| 44 | Mutism (HP:0002300) | 2.74536170 |
| 45 | Ankle clonus (HP:0011448) | 2.73375719 |
| 46 | Drooling (HP:0002307) | 2.71162531 |
| 47 | Excessive salivation (HP:0003781) | 2.71162531 |
| 48 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.69664151 |
| 49 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.69664151 |
| 50 | Papilledema (HP:0001085) | 2.68519248 |
| 51 | Amblyopia (HP:0000646) | 2.63928537 |
| 52 | Peripheral hypomyelination (HP:0007182) | 2.59710633 |
| 53 | Fetal akinesia sequence (HP:0001989) | 2.56369826 |
| 54 | Limb ataxia (HP:0002070) | 2.53576261 |
| 55 | Spinal canal stenosis (HP:0003416) | 2.53220753 |
| 56 | Supranuclear gaze palsy (HP:0000605) | 2.52483137 |
| 57 | Obstructive sleep apnea (HP:0002870) | 2.51256415 |
| 58 | Horizontal nystagmus (HP:0000666) | 2.50914114 |
| 59 | Lower limb asymmetry (HP:0100559) | 2.50026714 |
| 60 | Postural instability (HP:0002172) | 2.48851580 |
| 61 | Abnormality of saccadic eye movements (HP:0000570) | 2.48347785 |
| 62 | Epileptiform EEG discharges (HP:0011182) | 2.45330723 |
| 63 | Protruding tongue (HP:0010808) | 2.45003505 |
| 64 | Abnormality of the lower motor neuron (HP:0002366) | 2.44272235 |
| 65 | Torticollis (HP:0000473) | 2.44165201 |
| 66 | Absent speech (HP:0001344) | 2.39562483 |
| 67 | Focal dystonia (HP:0004373) | 2.38407083 |
| 68 | Inability to walk (HP:0002540) | 2.35064385 |
| 69 | Gait ataxia (HP:0002066) | 2.34411739 |
| 70 | Amyotrophic lateral sclerosis (HP:0007354) | 2.34197884 |
| 71 | Progressive inability to walk (HP:0002505) | 2.33953299 |
| 72 | Impaired vibratory sensation (HP:0002495) | 2.32897263 |
| 73 | Neurofibrillary tangles (HP:0002185) | 2.31739290 |
| 74 | Spastic gait (HP:0002064) | 2.30048950 |
| 75 | Stomatitis (HP:0010280) | 2.28812532 |
| 76 | Pointed chin (HP:0000307) | 2.28418077 |
| 77 | Bradykinesia (HP:0002067) | 2.26892851 |
| 78 | EEG with generalized epileptiform discharges (HP:0011198) | 2.25956061 |
| 79 | Panhypogammaglobulinemia (HP:0003139) | 2.24847891 |
| 80 | Cerebral hypomyelination (HP:0006808) | 2.24175359 |
| 81 | Urinary urgency (HP:0000012) | 2.23163037 |
| 82 | Lower limb muscle weakness (HP:0007340) | 2.20232116 |
| 83 | Combined immunodeficiency (HP:0005387) | 2.20105146 |
| 84 | Inappropriate behavior (HP:0000719) | 2.17009188 |
| 85 | Thyroiditis (HP:0100646) | 2.13911591 |
| 86 | Cerebral inclusion bodies (HP:0100314) | 2.13666666 |
| 87 | Hypsarrhythmia (HP:0002521) | 2.09966481 |
| 88 | Abnormality of eosinophils (HP:0001879) | 2.08479176 |
| 89 | Abnormality of the corticospinal tract (HP:0002492) | 2.08108396 |
| 90 | Iris hypopigmentation (HP:0007730) | 2.08016531 |
| 91 | Blue irides (HP:0000635) | 2.06233617 |
| 92 | Craniofacial dystonia (HP:0012179) | 2.05478881 |
| 93 | Agitation (HP:0000713) | 2.04806352 |
| 94 | Generalized hypopigmentation of hair (HP:0011358) | 2.02955785 |
| 95 | Hypoplasia of the thymus (HP:0000778) | 2.02840405 |
| 96 | Incomplete penetrance (HP:0003829) | 2.02706401 |
| 97 | Stomach cancer (HP:0012126) | 2.01827428 |
| 98 | Postural tremor (HP:0002174) | 2.01016778 |
| 99 | Ocular albinism (HP:0001107) | 1.97172665 |
| 100 | Abnormality of T cells (HP:0002843) | 1.94636371 |
| 101 | Limb dystonia (HP:0002451) | 1.94490411 |
| 102 | Ventricular fibrillation (HP:0001663) | 1.92952453 |
| 103 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.92002336 |
| 104 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.90882149 |
| 105 | IgG deficiency (HP:0004315) | 1.90841101 |
| 106 | Eczematoid dermatitis (HP:0000976) | 1.90283469 |
| 107 | Tetraplegia (HP:0002445) | 1.90219030 |
| 108 | Resting tremor (HP:0002322) | 1.89996666 |
| 109 | Generalized myoclonic seizures (HP:0002123) | 1.89596684 |
| 110 | Cortical visual impairment (HP:0100704) | 1.83972400 |
| 111 | Psychosis (HP:0000709) | 1.81526637 |
| 112 | Nonprogressive disorder (HP:0003680) | 1.80851990 |
| 113 | Megalencephaly (HP:0001355) | 1.80756191 |
| 114 | Sleep apnea (HP:0010535) | 1.79970959 |
| 115 | Memory impairment (HP:0002354) | 1.78474656 |
| 116 | Fair hair (HP:0002286) | 1.77169351 |
| 117 | Akinesia (HP:0002304) | 1.76798263 |
| 118 | Delusions (HP:0000746) | 1.76378126 |
| 119 | Dyskinesia (HP:0100660) | 1.76357638 |
| 120 | Abnormality of salivation (HP:0100755) | 1.74527046 |
| 121 | Recurrent fungal infections (HP:0002841) | 1.71144237 |
| 122 | Menstrual irregularities (HP:0000858) | 1.69447662 |
| 123 | Deeply set eye (HP:0000490) | 1.68796074 |
| 124 | Progressive microcephaly (HP:0000253) | 1.68753485 |
| 125 | Clonus (HP:0002169) | 1.67031079 |
| 126 | Polyphagia (HP:0002591) | 1.64022450 |
| 127 | Neuronal loss in central nervous system (HP:0002529) | 1.63855272 |
| 128 | Intellectual disability, severe (HP:0010864) | 1.60863850 |
| 129 | Termporal pattern (HP:0011008) | 1.60173848 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.48400038 |
| 2 | NTRK3 | 4.18579216 |
| 3 | CASK | 3.32919646 |
| 4 | MAP3K9 | 3.11304274 |
| 5 | TNIK | 3.08782746 |
| 6 | DAPK2 | 3.04342899 |
| 7 | MAP2K7 | 3.01861137 |
| 8 | MAP3K4 | 2.90062094 |
| 9 | MARK1 | 2.82209805 |
| 10 | RIPK4 | 2.81317770 |
| 11 | CDK19 | 2.72392573 |
| 12 | MINK1 | 2.56155854 |
| 13 | NTRK2 | 2.11584987 |
| 14 | PRPF4B | 2.09463730 |
| 15 | MAP3K12 | 2.08651884 |
| 16 | DAPK1 | 2.01831540 |
| 17 | PAK6 | 1.86391920 |
| 18 | MAP2K4 | 1.85617631 |
| 19 | MAP4K1 | 1.76811047 |
| 20 | FES | 1.62732830 |
| 21 | MAP3K10 | 1.55144258 |
| 22 | KSR1 | 1.48398253 |
| 23 | CDK5 | 1.48392498 |
| 24 | KSR2 | 1.46974734 |
| 25 | PLK2 | 1.46040426 |
| 26 | SIK2 | 1.45458973 |
| 27 | MAPK13 | 1.36690167 |
| 28 | STK38 | 1.35889512 |
| 29 | ITK | 1.35311977 |
| 30 | CCNB1 | 1.27449123 |
| 31 | NTRK1 | 1.27035390 |
| 32 | PRKCG | 1.25875225 |
| 33 | JAK1 | 1.22503924 |
| 34 | GRK5 | 1.19087877 |
| 35 | SGK2 | 1.18840201 |
| 36 | NLK | 1.15680698 |
| 37 | BMPR2 | 1.15077051 |
| 38 | * CAMKK1 | 1.10347255 |
| 39 | PAK3 | 1.10294348 |
| 40 | BRD4 | 1.06570888 |
| 41 | RIPK1 | 1.05130685 |
| 42 | STK11 | 1.02581575 |
| 43 | SGK223 | 1.00170221 |
| 44 | SGK494 | 1.00170221 |
| 45 | PRKD3 | 1.00023097 |
| 46 | OXSR1 | 0.99498780 |
| 47 | IKBKE | 0.96538452 |
| 48 | MAP3K13 | 0.95017923 |
| 49 | SGK3 | 0.93812342 |
| 50 | CDK18 | 0.93656168 |
| 51 | TAOK1 | 0.93406924 |
| 52 | ARAF | 0.90203621 |
| 53 | UHMK1 | 0.89762973 |
| 54 | CDK15 | 0.89675292 |
| 55 | SIK3 | 0.89577935 |
| 56 | GRK6 | 0.88789995 |
| 57 | CAMK2B | 0.88444199 |
| 58 | PRKCH | 0.87466615 |
| 59 | TYRO3 | 0.85702518 |
| 60 | LCK | 0.84902526 |
| 61 | PRKCQ | 0.83169012 |
| 62 | CDK14 | 0.82195127 |
| 63 | * CAMK2A | 0.81991525 |
| 64 | RAF1 | 0.81054993 |
| 65 | MAP3K2 | 0.80467246 |
| 66 | CDK11A | 0.80360707 |
| 67 | PNCK | 0.79029437 |
| 68 | PDK1 | 0.77421038 |
| 69 | FGFR3 | 0.77208694 |
| 70 | WNK1 | 0.75358953 |
| 71 | SGK1 | 0.74955561 |
| 72 | BTK | 0.74770777 |
| 73 | FGFR2 | 0.74245437 |
| 74 | DYRK1A | 0.73648632 |
| 75 | MARK2 | 0.72983917 |
| 76 | JAK2 | 0.72135382 |
| 77 | HCK | 0.70714735 |
| 78 | PASK | 0.70566289 |
| 79 | * CAMK1 | 0.70250277 |
| 80 | RET | 0.69856896 |
| 81 | PINK1 | 0.67894511 |
| 82 | TNK2 | 0.67313001 |
| 83 | MUSK | 0.67114736 |
| 84 | EPHA3 | 0.66109406 |
| 85 | MAPK12 | 0.61901009 |
| 86 | * CAMK4 | 0.61887528 |
| 87 | CSNK1G2 | 0.61619795 |
| 88 | PDPK1 | 0.60824335 |
| 89 | PTK2B | 0.58085899 |
| 90 | MAP3K1 | 0.57308505 |
| 91 | FYN | 0.57081772 |
| 92 | TAOK3 | 0.56975922 |
| 93 | PHKG2 | 0.56893118 |
| 94 | PHKG1 | 0.56893118 |
| 95 | TXK | 0.54405238 |
| 96 | HIPK2 | 0.53652709 |
| 97 | ZAP70 | 0.53638951 |
| 98 | MAPK7 | 0.53025889 |
| 99 | DYRK1B | 0.50681729 |
| 100 | ALK | 0.49754773 |
| 101 | NEK6 | 0.48625022 |
| 102 | EIF2AK3 | 0.48624539 |
| 103 | CAMK2G | 0.47630560 |
| 104 | SCYL2 | 0.47437221 |
| 105 | RPS6KA3 | 0.47054411 |
| 106 | YES1 | 0.45660698 |
| 107 | IRAK2 | 0.44753786 |
| 108 | TEC | 0.44272635 |
| 109 | AKT3 | 0.43893953 |
| 110 | PKN1 | 0.42586737 |
| 111 | DAPK3 | 0.41586510 |
| 112 | FRK | 0.41317436 |
| 113 | CAMK2D | 0.40413272 |
| 114 | TYK2 | 0.40184007 |
| 115 | MAP3K6 | 0.39034185 |
| 116 | LYN | 0.39025450 |
| 117 | PRKCE | 0.38885609 |
| 118 | CDK3 | 0.38251272 |
| 119 | PRKG1 | 0.36440636 |
| 120 | PRKCZ | 0.34732417 |
| 121 | MAPK10 | 0.34039516 |
| 122 | SYK | 0.33959847 |
| 123 | PRKCB | 0.32483600 |
| 124 | MAP3K7 | 0.32263322 |
| 125 | PRKACA | 0.30274360 |
| 126 | PRKCA | 0.29727612 |
| 127 | CDC42BPA | 0.27662788 |
| 128 | CSNK1A1 | 0.24968544 |
| 129 | TAOK2 | 0.24355910 |
| 130 | MAPK8 | 0.23534512 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.17745419 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.11931297 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.94490754 |
| 4 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.94093628 |
| 5 | * Long-term potentiation_Homo sapiens_hsa04720 | 2.92289576 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.90770505 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.81377293 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.74633793 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.70557598 |
| 10 | * Amphetamine addiction_Homo sapiens_hsa05031 | 2.46480051 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.35258156 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.24198735 |
| 13 | Long-term depression_Homo sapiens_hsa04730 | 2.16253678 |
| 14 | Taste transduction_Homo sapiens_hsa04742 | 2.03330018 |
| 15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.95378107 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.92600539 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.90477807 |
| 18 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.89834047 |
| 19 | * Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.89320156 |
| 20 | Renin secretion_Homo sapiens_hsa04924 | 1.80438743 |
| 21 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.75285372 |
| 22 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.66887771 |
| 23 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.64716864 |
| 24 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.63957812 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.63048279 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.58568976 |
| 27 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.45203222 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.43885073 |
| 29 | Gap junction_Homo sapiens_hsa04540 | 1.42345572 |
| 30 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.40634724 |
| 31 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.31260979 |
| 32 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.25717075 |
| 33 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.21175727 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.18684646 |
| 35 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.17849106 |
| 36 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.16625661 |
| 37 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.12112217 |
| 38 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.10980810 |
| 39 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.10585388 |
| 40 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.10468322 |
| 41 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.01044075 |
| 42 | Melanogenesis_Homo sapiens_hsa04916 | 0.97077946 |
| 43 | Glioma_Homo sapiens_hsa05214 | 0.96520231 |
| 44 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.96318717 |
| 45 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.95813722 |
| 46 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.93804629 |
| 47 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.91681416 |
| 48 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.91669480 |
| 49 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.88219887 |
| 50 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.84729854 |
| 51 | Axon guidance_Homo sapiens_hsa04360 | 0.84688000 |
| 52 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84588530 |
| 53 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.84575605 |
| 54 | Circadian rhythm_Homo sapiens_hsa04710 | 0.82703263 |
| 55 | Phototransduction_Homo sapiens_hsa04744 | 0.80475062 |
| 56 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.77626162 |
| 57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.76179823 |
| 58 | Measles_Homo sapiens_hsa05162 | 0.74388577 |
| 59 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.73943481 |
| 60 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.73696998 |
| 61 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 0.73546667 |
| 62 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.73501128 |
| 63 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69619770 |
| 64 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.67623107 |
| 65 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65845356 |
| 66 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64538373 |
| 67 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64179899 |
| 68 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.62469395 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59654332 |
| 70 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58358113 |
| 71 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58206205 |
| 72 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.57816804 |
| 73 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.56031650 |
| 74 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.55911374 |
| 75 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.55696903 |
| 76 | Hepatitis B_Homo sapiens_hsa05161 | 0.55643610 |
| 77 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.55429585 |
| 78 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.54793675 |
| 79 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.54456806 |
| 80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53498832 |
| 81 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53419111 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52527996 |
| 83 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51618847 |
| 84 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.51358410 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.51331006 |
| 86 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.50672473 |
| 87 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.50571358 |
| 88 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49745583 |
| 89 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.49032050 |
| 90 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.48841208 |
| 91 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.48323850 |
| 92 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.47127926 |
| 93 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.46692091 |
| 94 | Endometrial cancer_Homo sapiens_hsa05213 | 0.46553700 |
| 95 | * Alcoholism_Homo sapiens_hsa05034 | 0.45088900 |
| 96 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44756324 |
| 97 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.42910498 |
| 98 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.42446077 |
| 99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42062023 |
| 100 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.40219328 |
| 101 | Platelet activation_Homo sapiens_hsa04611 | 0.39925385 |
| 102 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.39823608 |
| 103 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38476324 |
| 104 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.37722540 |
| 105 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.36073190 |
| 106 | Endocytosis_Homo sapiens_hsa04144 | 0.33926919 |
| 107 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.32777075 |
| 108 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.32429546 |
| 109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.32098152 |
| 110 | Colorectal cancer_Homo sapiens_hsa05210 | 0.31931456 |
| 111 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.30160860 |
| 112 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.29123887 |
| 113 | * Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.28044620 |
| 114 | Bile secretion_Homo sapiens_hsa04976 | 0.27280511 |
| 115 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.24342695 |
| 116 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.24220596 |
| 117 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.21705319 |

